Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vered Stearns

Showing results (11-20 of 273) with videos related to

Pageof 28
Sort By:
Clinical Advances in Hematology & Oncology : H&O|April 29, 2009
Tamoxifen metabolism and its effect on endocrine treatment of breast cancerSusanne Briest, Vered Stearns
Pharmacology & Therapeutics|March 19, 2013
Pharmacogenomics of breast cancer therapy: an updateKelly Westbrook, Vered Stearns
Journal of Mammary Gland Biology and Neoplasia|July 28, 2012
Epigenetics as a therapeutic target in breast cancerRoisin Connolly, Vered Stearns
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2010
Personalized tamoxifen: a step closer but miles to goAditya Bardia, Vered Stearns
Breast Cancer Research and Treatment|February 18, 2010
Personal breast: customizing agents and biomarkers for optimal adjuvant endocrine therapyAditya Bardia, Vered Stearns
Breast Cancer Research : BCR|April 5, 2011
Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for managementStéphanie Gaillard, Vered Stearns
Oncology (Williston Park, N.Y.)|December 18, 2007
Chemotherapeutic Strategies for advanced breast cancerSusanne Briest, Vered Stearns
Medicine|April 27, 2013
Optimizing vitamin D concentrations for breast cancer risk reductionVered Stearns, Kala Visvanathan
Women'S Health (London, England)|October 7, 2009
Advances in the adjuvant and neoadjuvant treatment of breast cancerSusanne Briest, Vered Stearns
Expert Review of Anticancer Therapy|December 22, 2007
Adjuvant aromatase inhibitors and emerging quality-of-life considerationsSusanne Briest, Vered Stearns
Pageof 28

Showing results (11-20 of 273) with videos related to

Sort By:
Pageof 28
Clinical Advances in Hematology & Oncology : H&O|April 29, 2009
Tamoxifen metabolism and its effect on endocrine treatment of breast cancerSusanne Briest, Vered Stearns
Pharmacology & Therapeutics|March 19, 2013
Pharmacogenomics of breast cancer therapy: an updateKelly Westbrook, Vered Stearns
Journal of Mammary Gland Biology and Neoplasia|July 28, 2012
Epigenetics as a therapeutic target in breast cancerRoisin Connolly, Vered Stearns
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2010
Personalized tamoxifen: a step closer but miles to goAditya Bardia, Vered Stearns
Breast Cancer Research and Treatment|February 18, 2010
Personal breast: customizing agents and biomarkers for optimal adjuvant endocrine therapyAditya Bardia, Vered Stearns
Breast Cancer Research : BCR|April 5, 2011
Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for managementStéphanie Gaillard, Vered Stearns
Oncology (Williston Park, N.Y.)|December 18, 2007
Chemotherapeutic Strategies for advanced breast cancerSusanne Briest, Vered Stearns
Medicine|April 27, 2013
Optimizing vitamin D concentrations for breast cancer risk reductionVered Stearns, Kala Visvanathan
Women'S Health (London, England)|October 7, 2009
Advances in the adjuvant and neoadjuvant treatment of breast cancerSusanne Briest, Vered Stearns
Expert Review of Anticancer Therapy|December 22, 2007
Adjuvant aromatase inhibitors and emerging quality-of-life considerationsSusanne Briest, Vered Stearns
Pageof 28